Debt-to-equity of Jade Biosciences, Inc. from 30 Jun 2022 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Jade Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 31 Dec 2025.
Jade Biosciences, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 10%, a 98% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Jade Biosciences, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2025	10%	-602%	-98%	31 Dec 2025
Q3 2025	67%	+33%	+98%	30 Sep 2025
Q2 2025	285%	+265%	+1298%	30 Jun 2025
Q1 2025	-101%	-115%	-855%	31 Mar 2025
Q4 2024	613%	+601%	+5056%	31 Dec 2024
Q3 2024	34%	+24%	+250%	30 Sep 2024
Q2 2024	20%	+12%	+152%	30 Jun 2024
Q1 2024	13%	+7.2%	+116%	31 Mar 2024
Q4 2023	12%	+7.3%	+157%	31 Dec 2023
Q3 2023	9.6%	+6.2%	+184%	30 Sep 2023
Q2 2023	8.1%	+5.6%	+219%	30 Jun 2023
Q1 2023	6.2%			31 Mar 2023
Q4 2022	4.6%			31 Dec 2022
Q3 2022	3.4%			30 Sep 2022
Q2 2022	2.5%			30 Jun 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.